Pharmaceutical Giant, Glaxo Smithkline, successfully opposed grant of Israel Trademark No. 165333 for “head first and foremost”, as filed by Dr. Amnon Mosk. However, a second mark, for “treating headaches…head first and foremost” was allowed.
The story reminds me of a joke that was popular about 30 years ago in the UK:
Q. What is the best cure for headaches?
A. Nothing! - for Nothing acts faster than Annadin.
